CIK: 0001747821
Total reported value
$299.6M
Reporting period: 2023-09-30 · Number of holdings: 26
Decheng Capital Management III (Cayman), LLC disclosed 26 holdings in its latest 13F filing for the period ending 2023-09-30, with total reported value of $299.6M and a quarterly turnover rate of 0.0%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "D"
Decheng Capital Management III (Cayman), LLC's disclosed holdings carry a Herfindahl concentration index of 0.110 — mathematically equivalent to about 9 equally-sized positions, well below its 26 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes vary widely across the portfolio (a coefficient of variation of 1.39), with a handful of outsized bets alongside many smaller positions.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 13% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
No holding changes this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NVLSEUR | Alpine Immune Sciences INC | Stock-Other | 25.63% | — | — | |
| 2 | ZNTL | Zentalis Pharmaceuticals INC | Stock-Other | 14.06% | — | — | |
| 3 | AURA | Aura Biosciences INC | Stock-Other | 6.09% | — | +296.52% | |
| 4 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 5.69% | — | — | |
| 5 | ✓ | Acelyrin INC | Stock-Other | 5.26% | — | -0.39% | |
| 6 | RCUS | Arcus Biosciences INC | Stock-Other | 5.21% | — | — | |
| 7 | ✓ | 10x Genomics, Inc. | Stock-Other | 4.95% | — | — | |
| 8 | ✓ | Argenx Se Spon Adr Each Rep 1 | Stock-Other | 4.50% | — | — | |
| 9 | PACB | Pacific Biosciences Of Calif | Stock-Other | 4.08% | — | — | |
| 10 | ILMN | Illumina INC | Stock-Healthcare | 3.70% | — | — | |
| 11 | LNTH | Lantheus Holdings INC | Stock-Healthcare | 3.30% | — | — | |
| 12 | ✓ | Horizon Therapeutics PLC | Stock-Other | 3.05% | — | — | |
| 13 | PHAT | Phathom Pharmaceuticals INC | Stock-Other | 2.94% | — | — | |
| 14 | IMGNEUR | Immunogen INC | Stock-Other | 2.20% | — | — | |
| 15 | SGENUSD | Seagen INC | Stock-Other | 1.63% | — | — | |
| 16 | HLTHQ | Cue Health INC | Stock-Other | 1.32% | — | — | |
| 17 | ✓ | Beyondspring INC Shs | Stock-Other | 1.32% | — | — | |
| 18 | 430 | Terns Pharmaceuticals INC | Stock-Other | 1.20% | — | — | |
| 19 | EQ | Equillium INC | Stock-Other | 1.10% | — | — | |
| 20 | WHWK | Whitehawk Therapeutics INC | Stock-Other | 0.85% | — | — | |
| 21 | ATRC | Atricure INC | Stock-Other | 0.68% | — | — | |
| 22 | SCYXEUR | Scynexis INC | Stock-Other | 0.42% | — | — | |
| 23 | ✓ | Mersana Therapeutics INC | Stock-Other | 0.38% | — | — | |
| 24 | PYXS | Pyxis Oncology INC | Stock-Other | 0.22% | — | — | |
| 25 | WGS | Genedx Holdings CORP | Stock-Other | 0.13% | — | — | |
| 26 | TORCEUR | Adicet Bio INC | Stock-Other | 0.09% | — | -60.41% |
Performance for Q3 2026
—
Performance Last 4 Quarters
—
Based on 0 months of available history
Based on 43% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2023-09-30 | 26 | $299.6M | 0 | |
| 2023-06-30 | 25 | $318.8M | 0 | |
| 2023-03-31 | 24 | $247.9M | 0 | |
| 2022-12-31 | 26 | $267.2M | 0 | |
| 2022-09-30 | 26 | $275.8M | 0 | |
| 2022-06-30 | 25 | $263.7M | 0 | |
| 2022-03-31 | 24 | $326.3M | 0 |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2023-09-30 | 2023-12-12 | Amendment | View on EDGAR |
| 2023-09-30 | 2023-11-29 | Amendment | View on EDGAR |
| 2023-09-30 | 2023-11-13 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-07-28 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-10 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-09 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-08 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-01 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-10 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001962933
Total reported value
$299.7M
86 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002004843
Total reported value
$299.7M
68 stks
2026-06-30
AUM within 0.0% of this institution
CIK 0001977044
Total reported value
$299.7M
57 stks
2026-03-31
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001224962
Total reported value
$5.1B
94 stks
2026-03-31
1 of the top 5 holdings overlap, including Roivant Sciences Ltd.
CIK 0001290162
Total reported value
$1.4B
76 stks
2026-03-31
1 of the top 5 holdings overlap, including Roivant Sciences Ltd.
CIK 0001318153
Total reported value
$2.9M
3 stks
2024-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Zentalis Pharmaceuticals INC